Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Tempest Therpeutics (TPST)

Tempest Therpeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TPST
DateTimeSourceHeadlineSymbolCompany
21/05/202413:00GlobeNewswire Inc.Tempest to Participate in Upcoming Investor ConferencesNASDAQ:TPSTTempest Therpeutics Inc
13/05/202421:54Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TPSTTempest Therpeutics Inc
09/05/202421:29Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TPSTTempest Therpeutics Inc
09/05/202421:29GlobeNewswire Inc.Tempest Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:TPSTTempest Therpeutics Inc
09/05/202421:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TPSTTempest Therpeutics Inc
26/04/202421:05GlobeNewswire Inc.Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TPSTTempest Therpeutics Inc
09/04/202413:00GlobeNewswire Inc.Tempest Reports New Preclinical Data for TPST-1120 in RCC at the AACR Annual MeetingNASDAQ:TPSTTempest Therpeutics Inc
04/04/202413:00GlobeNewswire Inc.Tempest Announces Publication of Positive Data from Phase 1 Trial of TPST-1120 in Patients with Advanced Solid Tumors in Journal of Cancer Research CommunicationsNASDAQ:TPSTTempest Therpeutics Inc
19/03/202420:25GlobeNewswire Inc.Tempest Reports Year End 2023 Financial Results and Provides Business UpdateNASDAQ:TPSTTempest Therpeutics Inc
12/03/202412:00GlobeNewswire Inc.Tempest Presents New Data at the SITC 2024 Spring Scientific Meeting Supporting Potent Anti-tumor Activity of TPST-1120 in Multiple Cancer TypesNASDAQ:TPSTTempest Therpeutics Inc
05/03/202421:30GlobeNewswire Inc.Tempest Announces Upcoming Presentation of Preclinical Data for TPST-1120 in Renal Cell Carcinoma at the AACR Annual MeetingNASDAQ:TPSTTempest Therpeutics Inc
26/02/202413:00GlobeNewswire Inc.Tempest to Present at the 44th Annual TD Cowen Healthcare ConferenceNASDAQ:TPSTTempest Therpeutics Inc
14/02/202423:49Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TPSTTempest Therpeutics Inc
14/02/202419:12Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TPSTTempest Therpeutics Inc
08/02/202422:41Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TPSTTempest Therpeutics Inc
02/02/202421:30GlobeNewswire Inc.Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TPSTTempest Therpeutics Inc
05/01/202421:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TPSTTempest Therpeutics Inc
05/01/202421:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TPSTTempest Therpeutics Inc
05/01/202421:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TPSTTempest Therpeutics Inc
05/01/202421:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TPSTTempest Therpeutics Inc
05/01/202421:05GlobeNewswire Inc.Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TPSTTempest Therpeutics Inc
01/12/202321:15GlobeNewswire Inc.Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TPSTTempest Therpeutics Inc
20/11/202313:00GlobeNewswire Inc.Tempest to Present at the 35th Annual Piper Sandler Healthcare ConferenceNASDAQ:TPSTTempest Therpeutics Inc
17/11/202321:46Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:TPSTTempest Therpeutics Inc
17/11/202321:45Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:TPSTTempest Therpeutics Inc
17/11/202321:44Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:TPSTTempest Therpeutics Inc
17/11/202321:44Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:TPSTTempest Therpeutics Inc
17/11/202321:43Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:TPSTTempest Therpeutics Inc
17/11/202321:39Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TPSTTempest Therpeutics Inc
09/11/202322:28Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TPSTTempest Therpeutics Inc
 Showing the most relevant articles for your search:NASDAQ:TPST